-
Merck trashes both of its COVID vaccine candidates due to weak clinical data — Big medtech deals keep on turning — Moderna says its COVID-19 vaccine is less effective against the South African variant — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Interview w VSI
Discussion in 'Vascular Solutions' started by Anonymous, Mar 28, 2010 at 7:04 PM.